Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gene Therapy

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302275PMID 15103320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV vaccines 1983–2003

  2003cited by this paper
• A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

  2003cited by this paper
• Planning the Genome Institute's Future

  2003cited by this paper
• Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.

  2003cited by this paper
• CpG‐DNA aided cross‐presentation of soluble antigens by dendritic cells

  2002cited by this paper
• Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization

  2002cited by this paper
• HIV vaccine strategies.

  2002cited by this paper
• Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

  2002cited by this paper
• Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

  2002cited by this paper
• Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.

  2002cited by this paper
• Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice

  2002cited by this paper
• Diversity Considerations in HIV-1 Vaccine Selection

  2002cited by this paper
• Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF1

  2002cited by this paper
• Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda

  2002cited by this paper
• Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades

  2002cited by this paper
• Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes.

  2002cited by this paper
• A novel potent strategy for induction of immunity to HIV-1 reverse transcriptase in primates.

  2002cited by this paper
• Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development

  2001cited by this paper
• HIV in Europe--a growing threat.

  2001cited by this paper
• CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.

  2001cited by this paper
• Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile.

  2001cited by this paper
• Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.

  2001cited by this paper
• gp120: Biologic aspects of structural features.

  2001cited by this paper
• The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine

  2000cited by this paper
• Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.

  2000cited by this paper
• Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

  2000cited by this paper
• Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids

  2000cited by this paper
• Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.

  2000cited by this paper
• The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine1

  2000cited by this paper
• Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

  2000cited by this paper
• Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo

  2000cited by this paper
• Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.

  2000cited by this paper
• Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.

  1999cited by this paper
• IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

  1999cited by this paper
• Cytokine Molecular Adjuvants Modulate Immune Responses Induced by DNA Vaccine Constructs for HIV-1 and SIV

  1999cited by this paper
• Human immunodeficiency virus type 1 subtypes differ in disease progression.

  1999cited by this paper
• Immunostimulatory CpG Motifs Trigger a T Helper-1 Immune Response to Human Immunodeficiency Virus Type-1 (HIV-1) gp160 Envelope Proteins

  1999cited by this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cited by this paper
• Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.

  1998cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

  1998cited by this paper
• Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

  1998cited by this paper
• CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

  1998cited by this paper
• Role of Preimmunization Virus Sequences in Cellular Immunity in HIV-Infected Patients during HIV Type 1 MN Recombinant gp160 Immunization

  1998cited by this paper
• Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.

  1997cited by this paper
• Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.

  1997cited by this paper
• Immunodominant Glycoprotein 41 Epitope Identified by Seroreactivity in HIV Type 1-Infected Individuals

  1996cited by this paper
• Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies.

  1994cited by this paper
• Gene inoculation generates immune responses against human immunodeficiency virus type 1.

  1993cited by this paper
• Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.

  1992cited by this paper
• Neutralizing cross‐reactive and non‐neutralizing monoclonal antibodies to HIV‐1 gp 120

  1990cited by this paper
• Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

  1986cited by this paper

• Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing.

  2024cites this paper
• Human Dendritic Cells Transduced with Herpes Simplex Virus Amplicons Encoding Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Elicit Adaptive Immune Responses from Human Cells Engrafted into NOD/SCID Mice and Confer Partial Protection against HIV-1 Chal

  2019cites this paper
• HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV

  2017cites this paper
• Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses

  2017cites this paper
• Intranasal Vaccination against HIV-1 with Adenoviral Vector-Based Nanocomplex Using Synthetic TLR-4 Agonist Peptide as Adjuvant.

  2016cites this paper
• Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults

  2015cites this paper
• Neutralizing antibodies to HIV-1 induced by immunization

  2013cites this paper
• Evaluation of Heterologous Vaginal SHIV SF162p4 Infection Following Vaccination with a Polyvalent Clade B Virus-Like Particle Vaccine

  2012cites this paper
• Assessing the Immunogenicity of GTU®-based HIV-1 Multigene DNA Vaccines in Murine Models

  2011cites this paper
• RADKO AVI Natural polymorphisms and transmitted drug resistance in Estonian HIV-1 CRF06_cpx and its recombinant viruses

  2011cites this paper
• Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D.

  2011cites this paper
• Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.

  2011cites this paper
• HIV-1 specific humoral immune responses in healthy volunteers after HIV DNA prime-HIV MVA boost immunization

  2010cites this paper
• Polyvalent AIDS vaccines.

  2010cites this paper
• Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

  2010cites this paper
• HIV-1 specific humoral immune responses in healthy volunteers after DNA prime-MVA boost immunization

  2010cites this paper
• Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines

  2010cites this paper
• Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen

  2009cites this paper
• HIV-1 immune responses induced by natural infection or immunisation

  2009cites this paper
• Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.

  2009cites this paper
• Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits.

  2009cites this paper
• Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.

  2009cites this paper
• Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.

  2008cites this paper
• Viral sequence diversity: challenges for AIDS vaccine designs

  2008cites this paper
• Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.

  2008cites this paper
• Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.

  2008cites this paper
• A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice.

  2007cites this paper
• Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity

  2007cites this paper
• Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine

  2007cites this paper
• Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.

  2007cites this paper
• Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines.

  2007cites this paper
• Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.

  2007cites this paper
• Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications

  2007cites this paper
• A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.

  2007cites this paper
• Prime-boost immunization strategies against HIV-1

  2007influential citation
• Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

  2007cites this paper
• DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.

  2007cites this paper
• Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA).

  2006cites this paper
• A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.

  2006cites this paper
• Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.

  2006cites this paper
• Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

  2006cites this paper
• A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.

  2006cites this paper
• Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates

  2006cites this paper
• Therapeutic immunization for HIV

  2006cites this paper
• Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience

  2006cites this paper
• Immunological responses in genital HPV infections and etiology of cervical cancer

  2005cites this paper
• DNA Vaccines: Progress and Challenges1

  2005cites this paper
• Cross-Clade Protection Induced by Human Immunodeficiency Virus-1 DNA Immunogens Expressing Consensus Sequences of Multiple Genes and Epitopes From Subtypes A, B, C, and FGH

  2005cites this paper
• Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.

  2005cites this paper
• Human Dendritic Cells Transduced with Herpes Simplex Virus Amplicons Encoding Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Elicit Adaptive Immune Responses from Human Cells Engrafted into NOD/SCID Mice and Confer Partial Protection against HIV-1 Challenge

  2005cites this paper
• Current developments in viral DNA vaccines: shall they solve the unsolved?

  2005cites this paper
• The rationale behind a vaccine based on multiple HIV antigens.

  2005cites this paper
• Therapeutic vaccination against HIV

  2004cites this paper
• From Microbiology and Tumor Biology Center (MTC), Karolinska Institutet and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

  2004cites this paper
• Genetic Vaccines and Therapy

  2003cites this paper